These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 6344985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Stat bite: Treatment trials in the PDQ clinical trials database, by phase.
    J Natl Cancer Inst; 2004 Sep 15; 96(18):1355. PubMed ID: 15367566
    [No Abstract] [Full Text] [Related]

  • 4. Orphan products activities of the National Institutes of Health.
    Schepartz SA.
    Prog Clin Biol Res; 1983 Sep 15; 127():173-86. PubMed ID: 6889399
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical trials referral resource. Current clinical trials of G3139.
    Tock B, Zwiebel JA, Schoenfeldt M.
    Oncology (Williston Park); 2003 Sep 15; 17(9):1244-6, 1251-3, 1258. PubMed ID: 14569852
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Challenge to growth hormone trial.
    Lehrman S.
    Nature; 1993 Jul 15; 364(6434):179. PubMed ID: 8321300
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan 15; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 12. Slow start to phase 0 as researchers debate value.
    Twombly R.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):804-6. PubMed ID: 16788150
    [No Abstract] [Full Text] [Related]

  • 13. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R.
    J Natl Cancer Inst; 2005 May 18; 97(10):708-9. PubMed ID: 15900036
    [No Abstract] [Full Text] [Related]

  • 14. The role of the National Cancer Institute in drug development.
    Doroshow J.
    Clin Adv Hematol Oncol; 2005 Apr 18; 3(4):257-8. PubMed ID: 16166997
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Soviet-American cooperation in experimental and clinical chemotherapy from 1972 to 1979].
    Peredovchikova NI, Kiselev AV, Puchkov IuI, Komarova LE, Gorbunova VA.
    Vopr Onkol; 1980 Apr 18; 26(12):3-6. PubMed ID: 7008350
    [No Abstract] [Full Text] [Related]

  • 17. FDA cracks down on labeling, initiates trial result reporting.
    Osborne R, Waltz E.
    Nat Biotechnol; 2008 Nov 18; 26(11):1203-4. PubMed ID: 18997742
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity.
    Newell DR.
    Br J Cancer; 2001 May 18; 84(10):1289-90. PubMed ID: 11355935
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.